Gabriela N. Doeswijk

Comparison of the Therapeutic Response to Treatment with a ¹⁷⁷Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models

Simone U. Dalm, Julie Nonnekens, Gabriela N. Doeswijk et al. · Journal of Nuclear Medicine · 2015 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

⁶⁸Ga/¹⁷⁷Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology

Simone U. Dalm, Ingrid L. Bakker, Erik de Blois et al. · Journal of Nuclear Medicine · 2016 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Cationic Gd-DTPA Liposomes for Highly Efficient Labeling of Mesenchymal Stem Cells and Cell Tracking with MRI

Jamal Guenoun, Gerben A. Koning, Gabriela N. Doeswijk et al. · Cell Transplantation · 2011 · 69 citations · Full text

Pharmacy, Bioengineering, Cell Biology +17

Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response

Danny Feijtel, Gabriela N. Doeswijk, Nicole S. Verkaik et al. · Theranostics · 2020 · 48 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

<i>In vivo</i> quantitative assessment of cell viability of gadolinium or iron‐labeled cells using MRI and bioluminescence imaging

Jamal Guenoun, Alessandro Ruggiero, Gabriela N. Doeswijk et al. · Contrast Media & Molecular Imaging · 2012 · 39 citations

Medicine, Biomedical Sciences, Cell Biology +17